There are numerous randomized controlled studies showing that the intake of essential phospholipids (EPL) can reduce steatosis and improve liver function parameters. Based on these studies EPL are nam ...
Kirjoittaja: Leonid Lazebnik, MD, PhD, Dr. Med. Sci., Chavdar Pavlov, MD, PhD, Dr. Med. Sci., Kirill M Starostin, MD ja Branko Popovic, MDEFSM: 2022;2:220082DOI: 10.52778/efsm.22.0082Päivämäärä: 10.04.2022
Reducing harmful stress is a key challenge to preserve well-being. A recent, randomized, double-blind, placebo-controlled study in moderately stressed healthy adults (Clinicaltrials.gov: NCT03262376; ...
Phytotherapeutics are used in many countries to treat stress symptoms such as mild sleep disorders, anxiety, increased irritability, tension and nervous restlessness. An established combination prepar ...
Even in countries with a high standard of living, the intake of essential nutrients by breast-feeding women is often inadequate – with potentially negative effects on the development of their baby. A ...
Allergic rhinitis is a common problem with increasing prevalence. Two recent publications demonstrate that intranasal triamcinolone acetonide is an effective treatment that progressively improves nasa ...
Cutaneous abscesses are often caused by S. aureus. The most important therapeutic measure is drainage of the accumulated pus. Although the clinical benefit from additionally administering oral antibio ...
Probiotics such as Bacillus clausii reduce the occurrence of gastrointestinal side effects of commonly used medications such as antibiotics and proton pump inhibitors in placebo-controlled randomized ...
A systematic review and meta-analysis confirms that the probiotic Bacillus clausii is an effective treatment for acute diarrhea in childhood. It shortens the duration of diarrhea and associated hospit ...
Throughout the world, headache is one of the main causes of limitations in daily life and/or unfitness to work. 50% of sufferers never consult a doctor and instead turn to self-medication. A recently ...
Kirjoittaja: Luminita Constantin, MD, Marion Eberlin, PhD, Iva Igracki Turudic, MD ja Martin C. Michel, MDEFSM: 2022;2:220001DOI: 10.52778/efsm.22.0001Päivämäärä: 17.01.2022
For the first time since bisacodyl was licensed in the 1950s, an up-to-date review has provided a thorough summary of the pharmacological and clinical data concerning this prokinetic and secretagogic ...
